(PUK) Prudential - Ratings and Ratios
Exchange: NYSE • Country: Hong Kong • Currency: USD • Type: Common Stock • ISIN: US74435K2042
PUK EPS (Earnings per Share)
PUK Revenue
PUK: Life Insurance, Health Insurance, Asset Management, Investments, Savings
Prudential PLC ADR (NYSE:PUK) is a multinational life insurance and financial services company with a significant presence in Asia and Africa, offering a diverse range of products including savings and investments, wealth management, health and protection plans, as well as foreign exchange services. With a rich history dating back to 1848, the company has established itself as a major player in the industry, leveraging its extensive experience and expertise to cater to the evolving needs of its customers.
From a business perspective, Prudential PLC operates in a rapidly growing market, driven by increasing demand for life insurance and financial services in emerging economies. The companys diversified product portfolio and geographic presence position it well to capitalize on these trends, while its commitment to innovation and customer-centricity enables it to stay ahead of the competition.
Analyzing the companys recent performance, we observe a steady upward trend in its stock price, with the current price of $23.17. The stock is trading above its 20-day and 50-day moving averages, indicating a positive short-term momentum. Furthermore, the stocks relative strength index (RSI) is not provided, but the proximity to its 52-week high of $23.28 suggests a strong bullish sentiment.
Using the available
Based on the analysis, we can conclude that Prudential PLC ADR (NYSE:PUK) presents a compelling investment opportunity, driven by its solid business fundamentals, favorable industry trends, and positive technical indicators. As the company continues to execute its growth strategy and expand its presence in key markets, investors can expect a potential revaluation of the stock, making it an attractive buy for those seeking exposure to the life insurance and financial services sector.
Additional Sources for PUK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PUK Stock Overview
Market Cap in USD | 29,954m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1990-07-03 |
PUK Stock Ratings
Growth Rating | -17.7 |
Fundamental | 50.7 |
Dividend Rating | 32.4 |
Rel. Strength | 9.98 |
Analysts | 4.67 of 5 |
Fair Price Momentum | 24.14 USD |
Fair Price DCF | 40.28 USD |
PUK Dividends
Dividend Yield 12m | 2.23% |
Yield on Cost 5y | 1.78% |
Annual Growth 5y | -7.06% |
Payout Consistency | 89.9% |
Payout Ratio | 25.1% |
PUK Growth Ratios
Growth Correlation 3m | 87% |
Growth Correlation 12m | 48.2% |
Growth Correlation 5y | -78.9% |
CAGR 5y | -1.56% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | 0.34 |
Alpha | 24.34 |
Beta | 0.862 |
Volatility | 29.36% |
Current Volume | 904.3k |
Average Volume 20d | 655.2k |
As of June 17, 2025, the stock is trading at USD 23.96 with a total of 904,277 shares traded.
Over the past week, the price has changed by +0.42%, over one month by +2.92%, over three months by +20.40% and over the past year by +36.07%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Prudential (NYSE:PUK) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.68 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PUK is around 24.14 USD . This means that PUK is currently overvalued and has a potential downside of 0.75%.
Prudential has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy PUK.
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, PUK Prudential will be worth about 27.1 in June 2026. The stock is currently trading at 23.96. This means that the stock has a potential upside of +12.98%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 33.5 | 39.7% |
Analysts Target Price | 33.4 | 39.2% |
ValueRay Target Price | 27.1 | 13% |